Back to Webinars

The Clinical Utility of Hereditary Cancer Multi-Gene Testing

Wednesday, December 18, 2013
5:05am PST
52 minutes

Agenda

Quick Ambry Genetics Overview

BRCA 1/2 Testing Methodology

Analytic Sensitivity and Accuracy

Variant Classification Approach

Introduction to Ambry BRCA 1/2 Reports

Review of Multi Gene Tests and Data

Q&A

Steven Keiles

Mr. Keiles began working at Ambry in 2000 where he oversees the client services department. He is also involved in contracting, new product development, pricing, marketing, and research publication. Mr. Keiles obtained his masters degree in genetic counseling from Sarah Lawrence College in 1987. As a genetic counselor at Kaiser Permanente his responsibilities included clinic coordination, program implementation and counseling for all genetic referrals. He was elected the 2009 President of the National Society of Genetic Counselors, where he was responsible for leading the association and serving as the chief spokesperson. Mr. Keiles has more than 20 years of clinical experience and his research publications include molecular diagnostic testing for cystic fibrosis and pancreatitis.

6480bd1fb8467209227170
Elizabeth Chao
Medical Director
Elizabeth Chao, MD, FACMG is a Clinical Geneticist who is also board-certified in Clinical Molecular Genetics. She completed her training at the Children’s Hospital of Philadelphia and has nearly ten years of experience in the clinical laboratory. Currently she is on faculty at the University of California, Irvine as an attending Geneticist where she directs […]

        Dr. Chao graduated with honors from UCLA with a B.S. in Microbiology and Molecular Genetics and received her M.D. from the University of California, Irvine. She completed her training in Clinical Molecular Genetics at the Children’s Hospital of Philadelphia (CHOP) and previously served as Associate Director of the Genetic Diagnostic Lab at the University of Pennsylvania. As a Howard Hughes Scholar at the National Human Genome Research Institute (NHGRI), Dr. Chao specialized in genomic technologies such as the development of array-CGH, and applications to cancer genetics. Currently, Dr. Chao is also on faculty at UC Irvine where her research focuses on novel methods for interpreting DNA variants in genomic data sets.